Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

• Status: Not yet recruiting
• Trial end date: 2025-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the efficacy of Flucanzol versus L-mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. The investigator will look at vaginal swabs after 1, 6 and 12 months. The investigator included 252 patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Maastricht University Medical Center
• Treatments: Fluconazole

Criteria

Inclusion Criteria:

• • Women of at least 18 years old

• Recurrent vulvovaginal candidiasis (At least 3 episodes of clinical symptoms during the last year)

• Clinical and microbiological diagnosis of (recurrent) vulvovaginal candidiasis at time of consultation

• Capacity to understand, consent, and comply with the trial procedures

Exclusion Criteria:

• Mixed vaginal infections

• Pregnancy or the intention to become pregnant during the study period

• Women using systemic or topical antifungal medication during the last 2 weeks prior to inclusion

• Known allergies for Fluconazole or honey

• Candida with resistance for Fluconazole